© Drug Hunter Inc. 2018-2023
Home > EB-42486
oral G2019S-LRRK2 mut.-selective kinase inh.
>70x sel. for ParkinsonÕs mut. over WT, non-BP
from 50k cmpd HTS + homology-based opt.
J. Med. Chem., Nov. 16, 2020
ESCAPE Bio, South San Francisco, CA
EB-42486 (ESCAPE Bio oral G2019S-LRRK2 mutant-selective kinase inhibitor)
Drug Hunter is commited to helping industry innovators make informed decisions. Premium members have access to our library of the latest stories in science, written by scientists.
Request a trial to access insights powering the pros in our industry.
Molecules of the Month
Molecule of the Year